The global Insulin Delivery Device Market, valued at US$32.6 billion in 2024 stood at US$35.3 billion in 2025 and is ...

Embecta Corp. (US): Embecta Corp. was formed after a spin-off from Becton, Dickinson and Company (BD) in April 2022.

River Road Asset Management, an investment management company, released its “River Road Small Cap Value Fund” Q1 2025 ...

Shareholders of Becton, Dickinson & Co (Symbol: BDX) looking to boost their income beyond the stock's 2.5% annualized dividend yield can sell the December covered call at the $175 strike and ...

Embecta Corp. has a 1 year low of $9.49 and a 1 year high of $21.48. The firm has a market cap of $586.77 million, a price-to-earnings ratio of 10.04, a PEG ratio of 0.78 and a beta of 1.13.

Becton, Dickinson and Company (NYSE:BDX), a leading player in the medical supplies and devices sector with a market capitalization of $49.36 billion, is navigating a transformative period marked ...

Review which funds and institutions currently hold Becton Dickinson & Co (BDX:XNYS) stock for ownership information.

Review the current valuation for Becton Dickinson & Co (BDX:XNYS) stock based on a yearly calendar providing PE ratios, cash flow, EBITDA and other company valuation information.

PARSIPPANY, N.J., May 27, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based ...

Understand the cash flow statement for Becton, Dickinson and Company (BDX), learn where the money comes from and how the company spends it.